LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an ...

KUFSTEIN, Austria, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Emerging process solution provider Single Use Support has launched RoSS.PADL, an unprecedented platform system for standardizing homogenization and ...

Novo Holdings, the majority owner of weight loss drugmaker Novo Nordisk (NVO) (OTCPK:NONOF), announced Wednesday an agreement to acquire a roughly 60% controlling stake in Single Use Support, an ...

Single Use Support is a process solution provider for Biopharma single-use industry. Its core focus lies on solutions for protection, filling/draining, freezing/thawing, storing and shipping of any ...

With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals available in the treatment of countless medical conditions. However, the success of ...

KUFSTEIN, Austria, June 14, 2023 (GLOBE NEWSWIRE) -- The company has experienced significant growth in recent years with its two production sites in Europe, a local sales team in the USA and ...

Novo Holdings, the majority owner of weight loss drugmaker Novo Nordisk (NVO) (OTCPK:NONOF), announced Wednesday an agreement to acquire a roughly 60% controlling stake in Single Use Support, an ...